These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 17707553)

  • 1. Insight into the reactive form of the anticancer agent iproplatin.
    Volckova E; Weaver E; Bose RN
    Eur J Med Chem; 2008 May; 43(5):1081-4. PubMed ID: 17707553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of cis-dichloro-bis-isopropylamine platinum(II) as a major metabolite of iproplatin in humans.
    Pendyala L; Cowens JW; Chheda GB; Dutta SP; Creaven PJ
    Cancer Res; 1988 Jun; 48(12):3533-6. PubMed ID: 3370646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reaction of polynuclear platinum antitumor compounds with reduced glutathione studied by multinuclear (1H, 1H-15N gradient heteronuclear single-quantum coherence, and 195Pt) NMR spectroscopy.
    Oehlsen ME; Qu Y; Farrell N
    Inorg Chem; 2003 Sep; 42(18):5498-506. PubMed ID: 12950196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydrolysis triggers oxidation of a trans diamine platinum(II) anticancer complex.
    Pizarro AM; Munk VP; Navarro-Ranninger C; Sadler PJ
    Angew Chem Int Ed Engl; 2003 Nov; 42(43):5339-42. PubMed ID: 14613170
    [No Abstract]   [Full Text] [Related]  

  • 5. A surprisingly stable macrochelate formed from the reaction of cis dinuclear platinum antitumor compounds with reduced glutathione.
    Oehlsen ME; Hegmans A; Qu Y; Farrell N
    Inorg Chem; 2005 May; 44(9):3004-6. PubMed ID: 15847402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transfer of 4'-chloro-2,2':6',2"-terpyridine platinum(II) between human serum albumin, glutathione and other thiolate ligands. A possible selective natural transport mechanism for the delivery of platinum(II) drugs to tumour cells.
    Ross SA; Carr CA; Brïet JW; Lowe G
    Anticancer Drug Des; 2000 Dec; 15(6):431-9. PubMed ID: 11716436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reaction of Zn7metallothionein with cis- and trans-[Pt(N-donor)2Cl2] anticancer complexes: trans-Pt(II) complexes retain their N-donor ligands.
    Knipp M; Karotki AV; Chesnov S; Natile G; Sadler PJ; Brabec V; Vasák M
    J Med Chem; 2007 Aug; 50(17):4075-86. PubMed ID: 17665893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Theoretical analysis on the transition state of the anticancer drug trans-[PtCl2(isopropylamine)2] and its cis isomer binding to DNA purine bases.
    Zhou L
    J Phys Chem B; 2009 Feb; 113(7):2110-27. PubMed ID: 19173577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Equilibrium, kinetic and HPLC study of the reactions between platinum(II) complexes and DNA constituents in the presence and absence of glutathione.
    Bugarcić ZD; Soldatović T; Jelić R; Algueró B; Grandas A
    Dalton Trans; 2004 Nov; (22):3869-77. PubMed ID: 15540131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA binding of iproplatin and its divalent metabolite cis-dichloro-bis-isopropylamine platinum (II).
    Pendyala L; Arakali AV; Sansone P; Cowens JW; Creaven PJ
    Cancer Chemother Pharmacol; 1990; 27(3):248-50. PubMed ID: 2265462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical, structural and biological studies of cis-[Pt(3-Acpy)(2)Cl(2)].
    Tian T; Mutikainen I; van Wezel GP; Aliaga-Alcalde N; Reedijk J
    J Inorg Biochem; 2009 Sep; 103(9):1221-7. PubMed ID: 19635634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. cis-[(4R,5R)-4,5-bis(aminomethyl)-2,2-dimethyl-1,3-dioxolane-N,N']- (malonato-O,O')platinum(II), an anticancer agent.
    Cho SW; Cho Y; Kim DK; Shin W
    Acta Crystallogr C; 2000 Jun; 56(Pt 6):653-4. PubMed ID: 10902008
    [No Abstract]   [Full Text] [Related]  

  • 13. Characterization of platinum anticancer drug protein-binding sites using a top-down mass spectrometric approach.
    Hartinger CG; Tsybin YO; Fuchser J; Dyson PJ
    Inorg Chem; 2008 Jan; 47(1):17-9. PubMed ID: 18067289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of cis,trans,cis-[PtCl2(OCOCH3)2(NH3)2] by aqueous extracts of cancer cells.
    Nemirovski A; Kasherman Y; Tzaraf Y; Gibson D
    J Med Chem; 2007 Nov; 50(23):5554-6. PubMed ID: 17949066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Supramolecular nanoencapsulation as a tool: solubilization of the anticancer drug trans-dichloro(dipyridine)platinum(II) by complexation with beta-cyclodextrin.
    Horvath G; Premkumar T; Boztas A; Lee E; Jon S; Geckeler KE
    Mol Pharm; 2008; 5(2):358-63. PubMed ID: 18281942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the human metabolism of iproplatin.
    Pendyala L; Krishnan BS; Walsh JR; Arakali AV; Cowens JW; Creaven PJ
    Cancer Chemother Pharmacol; 1989; 25(1):10-4. PubMed ID: 2590996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platinum(II) catalysis and radical intervention in reductions of platinum(IV) antitumor drugs by ascorbic acid.
    Weaver EL; Bose RN
    J Inorg Biochem; 2003 Jul; 95(4):231-9. PubMed ID: 12818793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platinum(II) compounds with chelating ligands based on pyridine and pyrimidine: synthesis, characterizations, DFT calculations, cytotoxic assays and binding to a DNA model base.
    Roy S; Westmaas JA; Buda F; Reedijk J
    J Inorg Biochem; 2009 Sep; 103(9):1278-87. PubMed ID: 19656572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EXAFS structural study of platinum-based anticancer drugs degradation in presence of sulfur nucleophilic species.
    Provost K; Bouvet-Muller D; Crauste-Manciet S; Moscovici J; Olivi L; Vlaic G; Michalowicz A
    Biochimie; 2009 Oct; 91(10):1301-6. PubMed ID: 19607872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thiolate bridging and metal exchange in adducts of a zinc finger model and Pt(II) complexes: biomimetic studies of protein/Pt/DNA interactions.
    Almaraz E; de Paula QA; Liu Q; Reibenspies JH; Darensbourg MY; Farrell NP
    J Am Chem Soc; 2008 May; 130(19):6272-80. PubMed ID: 18422317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.